4//SEC Filing
Belldegrun Rebecka 4
Accession 0001209191-20-055039
CIK 0001741830other
Filed
Oct 15, 8:00 PM ET
Accepted
Oct 16, 3:46 PM ET
Size
11.6 KB
Accession
0001209191-20-055039
Insider Transaction Report
Form 4
Kronos Bio, Inc.KRON
Belldegrun Rebecka
Director
Transactions
- Conversion
Series A Preferred Stock
2020-10-14−228,315→ 0 total(indirect: By Trust)→ Common Stock (240,872 underlying) - Conversion
Common Stock
2020-10-14+182,866→ 438,703 total(indirect: By Trust) - Conversion
Common Stock
2020-10-14+240,872→ 679,575 total(indirect: By Trust) - Conversion
Series Seed Preferred Stock
2020-10-14−173,333→ 0 total(indirect: By Trust)→ Common Stock (182,866 underlying)
Footnotes (2)
- [F1]Each share of Series Seed Preferred Stock and Series A Preferred Stock (the "Preferred Stock") automatically converted into 1.055 shares of Common Stock upon the closing of the Issuer's initial public offering. The Preferred Stock had no expiration date.
- [F2]The reporting person is the beneficiary of Bellco Legacy II Trust ("Bellco") and her husband, Dr. Arie Belldegrun, currently serves as the trustee of Bellco.
Documents
Issuer
Kronos Bio, Inc.
CIK 0001741830
Entity typeother
Related Parties
1- filerCIK 0001827006
Filing Metadata
- Form type
- 4
- Filed
- Oct 15, 8:00 PM ET
- Accepted
- Oct 16, 3:46 PM ET
- Size
- 11.6 KB